Reneo Pharmaceuticals, Inc.
NASDAQ:RPHM
18.2 (USD) • At close October 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2001 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 27.632 | 19.927 | 124.66 | 53.613 | 17.501 | 0 |
| Short Term Investments
| 75.331 | 81.246 | 23.01 | 0 | 7.386 | 0 |
| Cash and Short Term Investments
| 102.963 | 101.173 | 147.67 | 53.613 | 24.887 | 0 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 3.659 | 5.18 | 12.128 | 1.412 | 0.519 | 0 |
| Total Current Assets
| 106.622 | 106.353 | 153.734 | 55.025 | 25.406 | 0 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 0.733 | 1.745 | 0.212 | 0.069 | 0.079 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.081 | 0.084 | 0.078 | 0.127 | 0.02 | 0 |
| Total Non-Current Assets
| 0.814 | 1.829 | 0.29 | 0.196 | 0.099 | 0 |
| Total Assets
| 107.436 | 108.182 | 154.024 | 55.221 | 25.505 | 0 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 8.717 | 1.893 | 2.022 | 0.908 | 0.542 | 0 |
| Short Term Debt
| 0.662 | 0.808 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 8.798 | 4.423 | 4.18 | 3.672 | 2.397 | 0 |
| Total Current Liabilities
| 18.177 | 7.124 | 6.202 | 4.58 | 2.939 | 0 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0.642 | 1.059 | 0 | 92.72 | 45.652 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0.167 | 0.036 | 0.041 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.007 | 0.029 | 0.611 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 0.649 | 1.088 | 0.611 | 92.756 | 45.693 | 0 |
| Total Liabilities
| 18.826 | 8.212 | 6.813 | 97.336 | 48.632 | 0 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 154.024 | 0.093 | 0.046 | 0 |
| Common Stock
| 0.003 | 0.003 | 0.003 | 0.001 | 0.001 | 0 |
| Retained Earnings
| -218.474 | -136.683 | -84.728 | -44.958 | -25.493 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 0.008 | -0.043 | 0.034 | -0.094 | 0.003 | 0 |
| Other Total Stockholders Equity
| 307.073 | 236.693 | 231.902 | 2.937 | 2.362 | 0 |
| Total Shareholders Equity
| 88.61 | 99.97 | 147.211 | -42.115 | -23.127 | 0 |
| Total Equity
| 88.61 | 99.97 | 147.211 | -42.115 | -23.127 | 0 |
| Total Liabilities & Shareholders Equity
| 107.436 | 108.182 | 154.024 | 55.221 | 25.505 | 0 |